Daymark Wealth Partners LLC Boosts Position in HCA Healthcare, Inc. (NYSE:HCA)

Daymark Wealth Partners LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 8.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,813 shares of the company’s stock after acquiring an additional 230 shares during the period. Daymark Wealth Partners LLC’s holdings in HCA Healthcare were worth $844,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Advisory Alpha LLC increased its position in HCA Healthcare by 14.3% during the fourth quarter. Advisory Alpha LLC now owns 1,118 shares of the company’s stock worth $336,000 after buying an additional 140 shares in the last quarter. Transform Wealth LLC raised its stake in HCA Healthcare by 12.7% in the 4th quarter. Transform Wealth LLC now owns 25,278 shares of the company’s stock valued at $7,587,000 after purchasing an additional 2,847 shares during the last quarter. Clear Harbor Asset Management LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth about $320,000. Clarius Group LLC lifted its stake in shares of HCA Healthcare by 19.1% during the fourth quarter. Clarius Group LLC now owns 1,540 shares of the company’s stock valued at $462,000 after buying an additional 247 shares during the period. Finally, Arkadios Wealth Advisors grew its stake in HCA Healthcare by 46.9% in the 4th quarter. Arkadios Wealth Advisors now owns 3,435 shares of the company’s stock worth $1,031,000 after acquiring an additional 1,096 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Morgan Stanley cut their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Truist Financial cut their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Price Performance

HCA opened at $325.18 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $278.68 and a twelve month high of $417.14. The company has a fifty day simple moving average of $314.50 and a 200 day simple moving average of $352.84. The firm has a market cap of $82.37 billion, a price-to-earnings ratio of 14.60, a PEG ratio of 1.08 and a beta of 1.64.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.